Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.
about
Venous thromboembolic diseaseVenous thromboembolism in cancer patients: an underestimated major health problemVenous thromboembolism in cancer patients.Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.The potential benefits of low-molecular-weight heparins in cancer patientsEvidence-based guidance on venous thromboembolism in patients with solid tumoursIs a subgroup claim believable? A user's guide to subgroup analyses in the surgical literatureTreatment and secondary prevention of venous thromboembolism in cancer.Cancer and coagulation.Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.Anticoagulation in the management of venous thromboembolism in the cancer patient.Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis.Extended Pharmacologic Thromboprophylaxis in Oncologic Liver Surgery is Safe and Effective.Venous thromboembolism in cancer patients: risk assessment, prevention and management.Thrombosis in cancer patients: etiology, incidence, and management.Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.The optimal anticoagulant therapy for mechanical heart valves in a gallbladder cancer patient with hepatic metastases: A case report
P2860
Q24631121-CE4B8B11-D205-4781-B72D-ED5660B0F8D3Q26852015-19A2A4DB-96E8-4E73-8F74-E0913A3500C6Q33419213-86F1EDA3-1BCC-440B-B126-CFB7C1898CB7Q33561213-09FBEF67-7368-4F25-9935-4B3A859D1040Q33698360-3C52AA80-C779-490A-85ED-D1670B2653E0Q33763946-031BDF48-2919-418B-8225-42D84BFA63F3Q34527654-128D2920-2CAB-41E2-9AC6-092334044C20Q35865373-68A7ECA9-B3FA-41D3-87F6-8068B3D14CC4Q36391554-38B0CF9E-DBC3-4010-A5D4-D3E78C9165B5Q37397597-FB7A7C48-8A93-4558-B5A4-3B94B41ACF2BQ37844474-FFB77AD2-7D58-46A4-8BF8-F5E31D54FA82Q38108138-F5C9BA3F-5FFF-4EE4-BCF4-970320A2779FQ38605635-38AE2646-A514-4B77-A053-E41F32EB25FAQ38751462-1C812C69-2006-468E-8795-D1F72A9D447CQ49332638-54145F10-3C03-4611-AC1E-05AEE9F6713EQ55364590-3FD9E1F7-09C5-4B20-8F53-EC12666B4161Q58739465-A2D382AD-039B-4474-A482-85DE59C3103B
P2860
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@ast
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@en
type
label
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@ast
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@en
prefLabel
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@ast
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@en
P2093
P50
P1476
Low-molecular-weight heparin v ...... atic review and meta-analysis.
@en
P2093
Deborah J Cook
Elena V Sempos
Elie A Akl
Holger J Schünemann
Paola Muti
P304
P356
10.1001/ARCHINTE.168.12.1261
P407
P577
2008-06-01T00:00:00Z